el-Agha M S, Johnston E W, Bowman R W, Cavanagh H D, McCulley J P
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, USA.
Trans Am Ophthalmol Soc. 2000;98:59-66; discussion 66-9.
To compare the efficacy and safety of photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) in the treatment of spherical hyperopia with use of the VISX STAR S2 excimer laser.
A review of 15 consecutive patients (22 eyes) receiving PRK and 22 consecutive patients (26 eyes) receiving LASIK (median follow-up, 12 months).
Mean age was 52 +/- 7 years for patients receiving PRK and 55 +/- 9 years for patients receiving LASIK. Mean preoperative spherical equivalent was +2.25 +/- 1.16 D for PRK patients and +1.81 +/- 0.92 D for LASIK patients. Mean deviation from intended correction was -0.82 +/- 0.89 D after PRK and +0.19 +/- 0.47 D after LASIK at 1 month (P < .01); +0.16 D +/- 0.37 D after PRK and +0.29 +/- 0.51 D after LASIK at 6 months (P = .906); +0.20 +/- 0.35 D after PRK and +0.37 +/- 0.44 D after LASIK at 1 year (P = .301). At 1 year, 83.3% of PRK eyes and 61.5% of hyperopic LASIK eyes were within +/- 0.50 D of intended correction (P = 1.0). At 1 year, all eyes in both groups had acuity of 20/40 or better uncorrected, and 47.1% of PRK eyes and 54.5% of LASIK eyes had acuity of 20/20 or better uncorrected (P = 1.0). At last follow-up (minimum, 6 months), 2 eyes in each group had lost 2 lines of best spectacle-correct visual acuity, but none had lost more than 2 lines. All PRK patients experienced significant postoperative pain that required systemic medication. LASIK patients had only minor, transient discomfort.
LASIK and PRK are of comparable efficacy and safety. However, PRK was associated with significant post-operative pain, an initial and temporary myopic overshoot peaking at 1 month, and stability not occurring before 6 months. LASIK was less painful and was associated with more rapid stability (at 1 month) and a trend toward better uncorrected visual acuity, although not statistically significant.
使用VISX STAR S2准分子激光比较准分子原位角膜磨镶术(LASIK)和准分子激光角膜切削术(PRK)治疗球面性远视的疗效和安全性。
回顾性研究15例连续接受PRK治疗的患者(22只眼)和22例连续接受LASIK治疗的患者(26只眼)(中位随访时间为12个月)。
接受PRK治疗的患者平均年龄为52±7岁,接受LASIK治疗的患者平均年龄为55±9岁。PRK患者术前平均球镜等效度为+2.25±1.16D,LASIK患者为+1.81±0.92D。PRK术后1个月时与预期矫正的平均偏差为-0.82±0.89D,LASIK术后为+0.19±0.47D(P<0.01);PRK术后6个月时为+0.16D±0.37D,LASIK术后为+0.29±0.51D(P = 0.906);PRK术后1年时为+0.20±0.35D,LASIK术后为+0.37±0.44D(P = 0.301)。1年时,83.3%的PRK术眼和61.5%的远视LASIK术眼在预期矫正的±0.50D范围内(P = 1.0)。1年时,两组所有术眼未矫正视力均达到20/40或更好,47.1%的PRK术眼和54.5%的LASIK术眼未矫正视力达到20/20或更好(P = 1.0)。在最后一次随访时(最短6个月),每组各有2只眼最佳矫正视力下降了2行,但均未超过2行。所有PRK患者术后均经历了严重疼痛,需要全身用药。LASIK患者仅有轻微、短暂的不适。
LASIK和PRK的疗效和安全性相当。然而,PRK与术后严重疼痛、1个月时出现的初始且暂时的近视过矫峰值以及6个月前未达到稳定状态有关。LASIK疼痛较轻,与更快达到稳定状态(1个月时)相关,且未矫正视力有更好的趋势,尽管无统计学意义。